Evidence map›Paper›PMID 32537676›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2020

Characterization, modes of action, and application of a novel broad-spectrum bacteriocin BM1300 produced by Lactobacillus crustorum MN047.

Yingying Lu, Rakhmanova Aizhan, Hong Yan, Xin Li, Xin Wang, Yanglei Yi, Yuanyuan Shan, Bianfang Liu, Yuan Zhou, Xin Lü

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Pacin, a novel bacteriocin fromMicrobiology spectrum · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Antibacterial Effect of Cell-Free Supernatant fromMolecules (Basel, Switzerland) · 2022
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yingying LuCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.ORCID http://orcid.org/0000-0002-8624-0464
Rakhmanova AizhanCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.
Hong YanCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.
Xin LiCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.
Xin WangCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.
Yanglei YiCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.
Yuanyuan ShanCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.
Bianfang LiuCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.
Yuan ZhouCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China.
Xin LüCollege of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi Province, China. xinlu@nwsuaf.edu.cn.

Funding

Special Fund for Agro-scientific Research in the Public Interest 201503135
6 · The paper itself

Abstract

Bacteriocins are ribosomally synthesized peptides with antibacterial activity against food-borne pathogenic bacteria that cause spoilage, possessing important potential for use as a natural preservative in the food industry. The novel bacteriocin BM1300 produced by Lactobacillus crustorum MN047 was identified after purification in this study. It displayed broad-spectrum antibacterial activity against some selected Gram-positive and Gram-negative bacteria. The minimum inhibitory concentration (MIC) values of BM1300 against Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 25922 were 13.4 μg/mL and 6.7 μg/mL, respectively. Moreover, BM1300 showed excellent thermal (between 60 and 120 °C), pH (2-11), and chemical (Tween-40, Tween-80, Triton X-100, and EDTA) stabilities. Time-kill curves revealed that BM1300 exhibited bactericidal activity against S. aureus and E. coli. The scanning and transmission electron microscopy indicated that BM1300 acted by disrupting the cell membrane integrity and increasing cell membrane permeabilization of indicator bacteria. The disruption of cell membrane integrity caused by BM1300 was further demonstrated by the uptake of propidium iodide (PI) and the release of intracellular lactate dehydrogenase (LDH) and nucleic acid and proteins. Moreover, BM1300 affected cell cycle distribution to exert antibacterial activity collaboratively. Meanwhile, BM1300 inhibited the growth of S. aureus and E. coli of beef meat and improved the microbiological quality of beef meat. These findings place BM1300 as a potential biopreservative in the food industry.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriocinsErythrocytesEscherichia coliGram-Negative BacteriaGram-Positive BacteriaHemolysisLactobacillusMiceMicrobial Sensitivity TestsAnti-Bacterial AgentsBacteriocinsApplicationBactericidal effectBacteriocinMultiple modes of actionPurification

Identifiers

PMID32537676
PMCPMC7688877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.